On September 27, 2019, Matthew L. Sherman, M.D. tendered his resignation from the board of directors and all Board committees, of Pulmatrix, Inc., effective on January 31, 2020. The resignation of Dr. Sherman was in connection with his recent appointment as Executive Vice President and Chief Medical Officer of Deciphera Pharmaceuticals, Inc. and not in connection with any disagreement with the Company on any matter relating to the Company's operations, policies, or practices.